Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma
Northwestern University
Northwestern University
Rutgers, The State University of New Jersey
University of Texas Southwestern Medical Center
University of Miami
Rutgers, The State University of New Jersey
Eastern Cooperative Oncology Group
Rutgers, The State University of New Jersey
Fred Hutchinson Cancer Center
Vanderbilt-Ingram Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center